Stay updated on Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page's displayed site revision was updated from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov record for a phase 2 study of fruquintinib maintenance therapy for metastatic colorectal cancer is available, with details about participation, treatments, study measures, and locations.SummaryDifference44%

- Check14 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide NIH notice about changes in terminology appears above the study record, and the site revision advances from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference1%

- Check42 days agoChange DetectedThe site revision marker in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record details with a generic error page. This indicates access is blocked or the record is unavailable.SummaryDifference18%

Stay in the know with updates to Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib Maintenance in Metastatic Colorectal Cancer Clinical Trial page.